| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,976,932 |
|
|
|
Indirect Value
|
$4,316,380 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,293,312 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4/A |
AS |
$19.30 |
$118,084 |
I/I |
(5,950) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-08 |
4 |
OE |
$5.28 |
$120,944 |
I/I |
22,906 |
189,523 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-08-19 |
4 |
S |
$49.31 |
$126,230 |
I/I |
(2,546) |
164,773 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-01-05 |
4 |
S |
$44.78 |
$127,399 |
I/I |
(2,845) |
163,285 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
AS |
$21.96 |
$128,730 |
D/D |
(5,862) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
AS |
$22.17 |
$129,495 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
AS |
$21.87 |
$129,776 |
D/D |
(5,863) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$19.93 |
$132,187 |
D/D |
(6,511) |
4,081 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
AS |
$23.91 |
$138,080 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4 |
AS |
$24.51 |
$152,503 |
D/D |
(6,135) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-03-29 |
4 |
AS |
$54.62 |
$154,126 |
I/I |
(2,822) |
162,319 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
AS |
$26.27 |
$154,319 |
D/D |
(5,862) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4/A |
AS |
$24.51 |
$155,194 |
D/D |
(6,242) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-09 |
4 |
OE |
$5.28 |
$158,400 |
I/I |
30,000 |
196,617 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-11 |
4 |
S |
$70.17 |
$221,972 |
I/I |
(3,156) |
172,233 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$20.21 |
$222,825 |
I/I |
(10,989) |
79,934 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4 |
AS |
$25.29 |
$238,864 |
I/I |
(9,445) |
132,670 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
AS |
$18.78 |
$241,943 |
I/I |
(12,883) |
90,923 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-08-23 |
4 |
AS |
$48.91 |
$300,454 |
I/I |
(6,143) |
158,630 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
0 |
- |
|
108 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
